A delegation of Russian maternal and child health experts has just met with their USAID counterparts to discuss bilateral collaboration on key MCH issues.

Last week, USP and the Ukraine Scientific Pharmacopoeial Centre for the Quality of Medicines agreed to share standards for the quality, purity, strength, and identity of medicines.

Russian biomedical plant Diod has set a price range of 30.55 to 40.74 roubles ($0.96-$1.28) per share for its June initial public offering in Moscow, its bookrunner said on Wednesday.

Russian pharmaceutical firm Protek posted a 4.4 percent rise in Q1 revenue in its debut results as a public company, helped by a 5.9 percent rise in its core drugs distribution arm.

The Russian government supports the U.S. company General Electric (GE) in an initiative to set up a joint venture with Russian companies in the energy sector and the health care system, Russian Prime Minister Vladimir Putin said at a meeting with GE Chairman and CEO Jeffrey Immelt here on last Friday.